Park Ha Biological Technology Co Share Price (NASDAQ: PHH)

$0.5

▲

-0.02

(-3.85%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Park Ha Biological Technology Co Stock chart to analyse performance

Park Ha Biological Technology Co stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$0.49
Today's High:$0.51
$0.50
2.0%
Downside
Day's Volatility :3.92%
Upside
1.96%
52 Weeks Low:$0.46
52 Weeks High:$41.49
$0.50
7.54%
Downside
52 Weeks Volatility :98.89%
Upside
98.79%

Park Ha Biological Technology Co Stock Returns

Period	Park Ha Biological Technology Co Ltd	Index (Russel 2000)
3 Months	-96.48%	0.0%
6 Months	-91.27%	0.0%
1 Year	-87.52%	0.0%
3 Years	-87.52%	-4.7%

Park Ha Biological Technology Co Ltd Key Stats

Check Park Ha Biological Technology Co key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.52
Open	$0.51
Today's High	$0.51
Today's Low	$0.49
Market Capitalization	$14.9M
Today's Volume	$468.6K
52 Week High	$41.49
52 Week Low	$0.4623
Revenue TTM	$2.8M
EBITDA	$-19.0M
Earnings Per Share (EPS)	$-0.72
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.22%
Return On Equity TTM	-729.77%

Stock Returns calculator for Park Ha Biological Technology Co Stock including INR - Dollar returns

The Park Ha Biological Technology Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Park Ha Biological Technology Co investment value today

Current value as on today

₹17,569

Returns

₹82,431

(-82.43%)

Returns from Park Ha Biological Technology Co Stock

₹87,715 (-87.71%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Park Ha Biological Technology Co Stock

-85%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Park Ha Biological Technology Co Stock from India on INDmoney has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Park Ha Biological Technology Co Stock

Rating

Trend

Park Ha Biological Technology Co Share Price Target

What analysts predicted

Upside of 2900.0%

Target:

$15.00

Current:

$0.50

Park Ha Biological Technology Co share price target is $15.00, a slight Upside of 2900.0% compared to current price of $0.50 as per analysts' prediction.

Park Ha Biological Technology Co Stock Insights

Price Movement
In the last 1 month, PHH stock has moved down by -35.2%

Park Ha Biological Technology Co Ltd Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY16

FY17

FY21

FY22

FY23

FY24

	FY16	Y/Y Change
Revenue	$622.0M	↓ 21.27%
Net Income	$-193.0M	↑ 47.33%
Net Profit Margin	-31.03%	↓ 14.45%

	FY17	Y/Y Change
Revenue	$456.0M	↓ 26.69%
Net Income	$-194.0M	↑ 0.52%
Net Profit Margin	-42.54%	↓ 11.51%

	FY21	Y/Y Change
Revenue	$931.0K	↓ 99.8%
Net Income	$-485.0K	↓ 99.75%
Net Profit Margin	-52.09%	↓ 9.55%

	FY22	Y/Y Change
Revenue	$1.9M	↑ 106.16%
Net Income	$191.3K	↓ 139.44%
Net Profit Margin	9.97%	↑ 62.06%

	FY23	Y/Y Change
Revenue	$2.5M	↑ 28.11%
Net Income	$852.0K	↑ 345.4%
Net Profit Margin	34.65%	↑ 24.68%

	FY24	Y/Y Change
Revenue	$2.4M	↓ 3.13%
Net Income	$478.6K	↓ 43.83%
Net Profit Margin	20.09%	↓ 14.56%

Q1 FY17

Q2 FY17

Q3 FY17

Q4 FY17

Q1 FY18

Q2 FY18

	Q1 FY17	Q/Q Change
Revenue	$114.0M	↑ 58.33%
Net Income	$-67.0M	↓ 49.62%
Net Profit Margin	-58.77%	↑ 125.95%

	Q2 FY17	Q/Q Change
Revenue	$112.0M	↓ 1.75%
Net Income	$-50.0M	↓ 25.37%
Net Profit Margin	-44.64%	↑ 14.13%

	Q3 FY17	Q/Q Change
Revenue	$121.0M	↑ 8.04%
Net Income	$-42.0M	↓ 16.0%
Net Profit Margin	-34.71%	↑ 9.93%

	Q4 FY17	Q/Q Change
Revenue	$109.0M	↓ 9.92%
Net Income	$-31.0M	↓ 26.19%
Net Profit Margin	-28.44%	↑ 6.27%

	Q1 FY18	Q/Q Change
Revenue	$50.0M	↓ 54.13%
Net Income	$-30.0M	↓ 3.23%
Net Profit Margin	-60.0%	↓ 31.56%

	Q2 FY18	Q/Q Change
Revenue	$35.0M	↓ 30.0%
Net Income	$-37.0M	↑ 23.33%
Net Profit Margin	-105.71%	↓ 45.71%

FY16

FY17

FY21

FY22

FY23

FY24

	FY16	Y/Y Change
Profit	$622.0M	↓ 21.27%

	FY17	Y/Y Change
Profit	$456.0M	↓ 26.69%

	FY21	Y/Y Change
Profit	$619.9K	↓ 99.86%

	FY22	Y/Y Change
Profit	$1.4M	↑ 127.5%

	FY23	Y/Y Change
Profit	$2.1M	↑ 52.32%

	FY24	Y/Y Change
Profit	$2.2M	↑ 1.82%

Q1 FY17

Q2 FY17

Q3 FY17

Q4 FY17

Q1 FY18

Q2 FY18

	Q1 FY17	Q/Q Change
Profit	$114.0M	↑ 58.33%

	Q2 FY17	Q/Q Change
Profit	$112.0M	↓ 1.75%

	Q3 FY17	Q/Q Change
Profit	$121.0M	↑ 8.04%

	Q4 FY17	Q/Q Change
Profit	$109.0M	↓ 9.92%

	Q1 FY18	Q/Q Change
Profit	$50.0M	↓ 54.13%

	Q2 FY18	Q/Q Change
Profit	$35.0M	↓ 30.0%

FY16

FY17

FY21

FY22

FY23

FY24

	FY16	Y/Y Change
Operating Cash Flow	$73.0M	↓ 39.67%
Investing Cash Flow	$50.0M	↓ 19.35%
Financing Cash Flow	$-123.0M	↓ 77.05%

	FY17	Y/Y Change
Operating Cash Flow	$303.0M	↑ 315.07%
Investing Cash Flow	$197.0M	↑ 294.0%
Financing Cash Flow	$-864.0M	↑ 602.44%

	FY21	Y/Y Change
Operating Cash Flow	$-497.9K	↓ 100.16%
Investing Cash Flow	$-12.9K	↓ 100.01%
Financing Cash Flow	$498.6K	↓ 100.06%

	FY22	Y/Y Change
Operating Cash Flow	$1.4M	↓ 389.7%
Investing Cash Flow	$-1.5M	↑ 11890.47%
Financing Cash Flow	$669.7K	↑ 34.3%

	FY23	Y/Y Change
Operating Cash Flow	$126.5K	↓ 91.23%
Investing Cash Flow	$1.0M	↓ 166.13%
Financing Cash Flow	$-676.9K	↓ 201.09%

	FY24	Y/Y Change
Operating Cash Flow	$960.5K	↑ 659.04%
Investing Cash Flow	$-508.1K	↓ 149.65%
Financing Cash Flow	$-957.4K	↑ 41.43%

Q1 FY17

Q2 FY17

Q3 FY17

Q4 FY17

Q1 FY18

Q2 FY18

	Q1 FY17	Q/Q Change
Operating Cash Flow	$192.0M	↑ 262.26%
Investing Cash Flow	$18.0M	↓ 126.87%
Financing Cash Flow	$-180.0M	↑ 136.84%

	Q2 FY17	Q/Q Change
Operating Cash Flow	$-142.0M	↓ 173.96%
Investing Cash Flow	$21.0M	↑ 16.67%
Financing Cash Flow	$186.0M	↓ 203.33%

	Q3 FY17	Q/Q Change
Operating Cash Flow	$-53.0M	↓ 62.68%
Investing Cash Flow	$101.0M	↑ 380.95%
Financing Cash Flow	$-555.0M	↓ 398.39%

	Q4 FY17	Q/Q Change
Operating Cash Flow	$306.0M	↓ 677.36%
Investing Cash Flow	$57.0M	↓ 43.56%
Financing Cash Flow	$-315.0M	↓ 43.24%

	Q1 FY18	Q/Q Change
Operating Cash Flow	$163.0M	↓ 46.73%
Investing Cash Flow	$5.0M	↓ 91.23%
Financing Cash Flow	$-215.0M	↓ 31.75%

	Q2 FY18	Q/Q Change
Operating Cash Flow	$-55.0M	↓ 133.74%
Investing Cash Flow	$2.0M	↓ 60.0%
Financing Cash Flow	$12.0M	↓ 105.58%

Park Ha Biological Technology Co Technicals Summary

Sell

Neutral

Buy

Park Ha Biological Technology Co is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Park Ha Biological Technology Co Ltd Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Park Ha Biological Technology Co Ltd	-22.89%	-91.27%	-87.52%	-87.52%	-87.52%
Colgate-palmolive Co.	0.25%	-9.43%	-22.01%	5.34%	7.65%
Procter & Gamble Company, The	4.37%	-10.56%	-10.01%	12.47%	13.66%
Estée Lauder Companies Inc.	-1.72%	30.71%	-0.86%	-63.48%	-58.49%
Kenvue Inc.	-3.4%	-12.95%	-6.29%	-23.01%	-23.01%
Kimberly-clark Corp.	3.59%	-9.94%	-12.39%	0.45%	-16.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Park Ha Biological Technology Co Ltd	26.91	NA	-4.39	0.0	-7.3	-2.98	NA	0.14
Colgate-palmolive Co.	23.62	23.62	1.81	3.68	0.4	0.16	0.02	0.87
Procter & Gamble Company, The	24.12	24.12	3.77	6.78	0.31	0.11	0.03	21.88
Estée Lauder Companies Inc.	124.05	NA	1.97	1.49	-0.25	0.03	0.02	10.74
Kenvue Inc.	27.39	27.39	1.13	1.03	0.14	0.07	0.04	5.59
Kimberly-clark Corp.	17.67	17.67	5.62	7.52	1.84	0.11	0.04	3.83

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Park Ha Biological Technology Co Ltd	NA	$14.9M	-87.52%	26.91	0.0%
Colgate-palmolive Co.	Buy	$67.9B	7.65%	23.62	14.54%
Procter & Gamble Company, The	Buy	$367.8B	13.66%	24.12	18.95%
Estée Lauder Companies Inc.	Hold	$33.0B	-58.49%	124.05	-7.91%
Kenvue Inc.	Buy	$39.4B	-23.01%	27.39	9.37%
Kimberly-clark Corp.	Hold	$42.8B	-16.31%	17.67	12.32%

About Park Ha Biological Technology Co Ltd

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Organization	Park Ha Biological Technology Co
Employees	17
CEO	Ms. Xiaoqiu Zhang
Industry	Miscellaneous

Key Management of Park Ha Biological Technology Co Ltd

Name	Title
Ms. Xiaoqiu Zhang	CEO & Chairman of the Board
Ms. Xiaoyan Zhu	Chief Financial Officer
Ms. Xinyu Li	CTO & Product Manager

Important FAQs about investing in PHH Stock from India :

What is Park Ha Biological Technology Co share price today?

Park Ha Biological Technology Co share price today is $0.50 as on August 30, 2025 at 1:29 am IST at the close of the market. Park Ha Biological Technology Co share today touched a day high of $0.51 and a low of $0.49.

What is the 52 week high and 52 week low for Park Ha Biological Technology Co share?

Park Ha Biological Technology Co share touched a 52 week high of $41.49 and a 52 week low of $0.46. Park Ha Biological Technology Co stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $0.50, lower by 98.79% versus the 52 week high.

How to invest in Park Ha Biological Technology Co Stock (PHH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Park Ha Biological Technology Co on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Park Ha Biological Technology Co Shares that will get you 3.0000 shares as per Park Ha Biological Technology Co share price of $0.50 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Park Ha Biological Technology Co Stock (PHH) from India?

Indian investors can start investing in Park Ha Biological Technology Co (PHH) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Park Ha Biological Technology Co stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Park Ha Biological Technology Co share’s latest price of $0.50 as on August 30, 2025 at 1:29 am IST, you will get 20.0000 shares of Park Ha Biological Technology Co. Learn more about fractional shares .

What are the returns that Park Ha Biological Technology Co has given to Indian investors in the last 5 years?

Park Ha Biological Technology Co stock has given -87.52% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?